Liu H - Search Results

1

Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.

Ai B, Liu H, Huang Y, Peng P. Ai B, et al. Among authors: liu h. Oncotarget. 2016 Jul 12;7(28):44583-44595. doi: 10.18632/oncotarget.10069. Oncotarget. 2016. PMID: 27323821 Free PMC article.

2

SGLT1 is required for the survival of triple-negative breast cancer cells via potentiation of EGFR activity.

Liu H, Ertay A, Peng P, Li J, Liu D, Xiong H, Zou Y, Qiu H, Hancock D, Yuan X, Huang WC, Ewing RM, Downward J, Wang Y. Liu H, et al. Among authors: liu d. Mol Oncol. 2019 Sep;13(9):1874-1886. doi: 10.1002/1878-0261.12530. Epub 2019 Jun 14. Mol Oncol. 2019. PMID: 31199048 Free PMC article.

3

WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer.

Ertay A, Liu H, Liu D, Peng P, Hill C, Xiong H, Hancock D, Yuan X, Przewloka MR, Coldwell M, Howell M, Skipp P, Ewing RM, Downward J, Wang Y. Ertay A, et al. Among authors: liu h, liu d. Cell Death Dis. 2020 Nov 21;11(11):1001. doi: 10.1038/s41419-020-03210-5. Cell Death Dis. 2020. PMID: 33221821 Free PMC article.

4

Correction: WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer.

Ertay A, Liu H, Liu D, Peng P, Hill C, Xiong H, Hancock D, Yuan X, Przewloka MR, Coldwell M, Howell M, Skipp P, Ewing RM, Downward J, Wang Y. Ertay A, et al. Among authors: liu h, liu d. Cell Death Dis. 2021 Mar 15;12(3):269. doi: 10.1038/s41419-021-03530-0. Cell Death Dis. 2021. PMID: 33723224 Free PMC article. No abstract available.

5

Association of miR-608 rs4919510 polymorphism and cancer risk: a meta-analysis based on 13,664 subjects.

Liu H, Zhou Y, Liu Q, Xiao G, Wang B, Li W, Ye D, Yu S. Liu H, et al. Among authors: liu q. Oncotarget. 2017 Jun 6;8(23):37023-37031. doi: 10.18632/oncotarget.9509. Oncotarget. 2017. PMID: 27223084 Free PMC article.

6

Decreased DACH1 expression in glomerulopathy is associated with disease progression and severity.

Liu QQ, Zhou YQ, Liu HQ, Qiu WH, Liu H, Hu TY, Xu Q, Lv YM, Wu KM. Liu QQ, et al. Among authors: liu h, liu hq. Oncotarget. 2016 Dec 27;7(52):86547-86560. doi: 10.18632/oncotarget.13470. Oncotarget. 2016. PMID: 27888806 Free PMC article.

7

Development and validation of a clinically applicable score to classify cachexia stages in advanced cancer patients.

Zhou T, Wang B, Liu H, Yang K, Thapa S, Zhang H, Li L, Yu S. Zhou T, et al. Among authors: liu h. J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):306-314. doi: 10.1002/jcsm.12275. Epub 2018 Jan 25. J Cachexia Sarcopenia Muscle. 2018. PMID: 29372594 Free PMC article.

8

Wang B, Thapa S, Zhou T, Liu H, Li L, Peng G, Yu S. Wang B, et al. Among authors: liu h. Support Care Cancer. 2020 Feb;28(2):581-588. doi: 10.1007/s00520-019-04717-0. Epub 2019 May 17. Support Care Cancer. 2020. PMID: 31102055

9

A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.

Fu X, Tian Z, Wen S, Sun H, Thapa S, Xiong H, Liu H, Li L, Yu S. Fu X, et al. Among authors: liu h. Nutrition. 2021 Feb;82:111032. doi: 10.1016/j.nut.2020.111032. Epub 2020 Oct 12. Nutrition. 2021. PMID: 33172686

10

Targeting glia for bone cancer pain.

Zhou YQ, Liu Z, Liu HQ, Liu DQ, Chen SP, Ye DW, Tian YK. Zhou YQ, et al. Expert Opin Ther Targets. 2016 Nov;20(11):1365-1374. doi: 10.1080/14728222.2016.1214716. Epub 2016 Jul 27. Expert Opin Ther Targets. 2016. PMID: 27428617 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95,671 results

Search Page

Filters